Triumeq 600 mg (Abacavir (Abacavir Sulfate) TABLET) 600 MG

TRIUMEQ 600 MG tablets contain abacavir sulfate, an antiretroviral medication used to manage HIV. This oral treatment is part of combination therapy for HIV-1 infection.

Strength

600 MG

Pack Size

Manufacturer / TM Owner

VIIV HEALTHCARE ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TRIUMEQ 600 MG tablets are primarily used in the treatment of HIV-1 infection. This medication is often prescribed as part of a combination therapy to help manage the virus. Abacavir sulfate works by inhibiting the reverse transcriptase enzyme, which is essential for the replication of HIV. Patients should follow their healthcare provider's instructions for the best results.

Side Effects

Common effects of TRIUMEQ 600 MG tablets may include headache, nausea, and fatigue. Some individuals might experience dizziness or stomach discomfort. It's important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

TRIUMEQ 600 MG tablets should be handled with care. Patients with a history of liver problems or allergic reactions to abacavir should inform their healthcare provider. Regular monitoring is advised to ensure the medication's safety and effectiveness. Always follow the prescribed dosage and administration guidelines.

Avoid Interactions

TRIUMEQ 600 MG tablets may interact with other medications, including certain antiretrovirals and drugs metabolized by the liver. Alcohol consumption should be avoided as it can exacerbate side effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Frequently Asked Questions

TRIUMEQ 600 MG tablets are used in combination therapy to manage HIV-1 infection.

TRIUMEQ 600 MG tablets are taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include headache, nausea, fatigue, dizziness, and stomach discomfort.

Patients should consult their healthcare provider before taking TRIUMEQ 600 MG with other medications to avoid potential interactions.

Patients with a history of liver problems or allergic reactions to abacavir should inform their healthcare provider before taking TRIUMEQ 600 MG.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.